Navigation Links


Virology in Medical Technology

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

... "We're pleased to see that the ARTEN study met its primary endpoint," said Peter Piliero, M.D., executive director of Medical Affairs, virology for Boehringer Ingelheim Pharmaceuticals, Inc. "The study also provides additional important data on the effect of VIRAMUNE on patient lipid profiles ...

MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants

... preterm infants 32-to-35 weeks gestational age (GA) in outpatient settings during their first year of life. The study also seeks to gather virology data regarding the national onset of the RSV season across the four geographic regions established by the U.S. Centers for Disease Control & ...

Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009

... Army Medical Research Institute of Infectious Diseases (USAMRIID); The Centers for Disease Control and Prevention (CDC); The National Institute of virology (NIV); The Battelle Biomedical Research Center (BBRC); and The Southwest Foundation for Biomedical Research (SFBR). Beyond therapeutic market ...

Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009

... in Oncology Building on scientific expertise and excellence in the fields of pulmonary and cardiovascular medicine, metabolic disease, neurology, virology and immunology, Boehringer Ingelheim has embarked on a major research program to develop innovative cancer drugs. Working in close collaboration with ...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

... to develop new therapies that will meet the needs of a growing population of patients with hepatitis C," said Rob Mitchell, Global Head of Roche's virology business. "We are hopeful that a combination of R7128 and the current gold standard of PEGASYS and COPEGUS can provide a more potent - and ...

Midwest Research Institute Launches Clinical Molecular Diagnostics Laboratory

... by public health and criminal laboratories to identify pathogens within complex environmental samples. MRI will have an exhibit at the Clinical virology Symposium that will be held in Daytona Beach, Fla., April 19-22 at the Hilton Daytona Beach Oceanfront Resort. MRI staff will be available at the ...

Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research

... Dr. Gallo and his team and other organizations that perform distinguished and creative scientific and translational research in the field of human virology and cancer, with a primary focus on HIV. In his new role, Nuschese will connect those around the world who wish to see an end to the AIDS epidemic, ...

Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds

... Intended for Journalists in the UK or Ireland - New Findings From ARTEMIS and TITAN Studies Demonstrate Growth of the Tibotec virology Franchise GLASGOW, Scotland, Nov. 12 /PRNewswire/ -- New data on PREZISTA(R) (darunavir), a protease inhibitor from Tibotec, will be presented at ...

Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C

... of HCV treatment and the preferred pegylated interferon therapy of choice for most HCV antiviral agents in development. Nick Cammack, Leader of the virology Disease Biology Leadership Team at Roche stated: "It is exciting to be at the forefront of designing innovative clinical approaches in fighting this ...

Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008

... and development of new treatments is critical to improving the standard of care for the millions of people living with this disease." As a global virology leader committed to patient care, Tibotec uses innovative science and expertise to research, develop, and manufacture, drugs for medical conditions ...

Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV

... - Once-daily TMC278, the third anti-HIV compound to be developed in Tibotec virology portfolio - YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. announced today that two major phase III efficacy trials examining ...

Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU

... the development of innovative, therapeutic and prophylactic products against viral infections and cancer. "Our strength is our extensive know-how in virology and our network of renowned national and international partners in academia and industry," says Joachim Seipelt, Co-Founder and Vice President for ...

Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations

... unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward gastroenterology, virology -- including human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections -- and oncology. Progenics, in collaboration with Wyeth, ...

Basic Science Discoveries Yield Progress in Hepatology

... Advances in virology Translate Into New Promising Drugs to Combat Hepatitis C Clarification of Oncogenic Pathways Aids Liver Cancer ...

Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica

... molecular genetics, with New York state permits in the categories of genetic testing, molecular oncology, molecular and cellular tumor markers; and virology general, virology limited to molecular techniques - currently performing over 30,000 tests per year in these categories. The laboratory is a ...

New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy

... of Ortho Biotech Products, L.P., a subsidiary of Johnson & Johnson, headquartered in Bridgewater, N.J., is dedicated to delivering innovative virology therapeutics that help healthcare professionals address serious unmet needs in people living with HIV. Tibotec Pharmaceuticals Ltd. Tibotec ...

Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma

... and analysis of the peramivir Phase II trial may differ from the preliminary results and analysis, that the additional pharmacokinetic studies and virology analysis being performed on peramivir may not support our post hoc analysis of the Phase II results, that DHHS and the FDA may not agree with our ...

Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis

... a large Phase 2b study examining the safety and efficacy of valomaciclovir against herpes zoster infection. Epiphany was founded by a world-class virology team, including two Lasker Award winners. Epiphany is located in San Francisco, CA. Additional information on Epiphany Biosciences may be obtained at ...

BioCryst Provides Forodesine HCl Update

... and analysis of the peramivir Phase II trial may differ from the preliminary results and analysis, that the additional pharmacokinetic studies and virology analysis being performed on peramivir may not support our post hoc analysis of the Phase II results, that DHHS and the FDA may not agree with our ...

Bristol-Myers Squibb, New Jersey Children's Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS

... Bristol-Myers Squibb, we believe that together we can prevail over serious illness," said Jill DeSimone, senior vice president of the company's U.S. virology division. "We are committed as a company in the battle against HIV/AIDS here in our community and throughout the world, and we stand united with ...

Childhood Influenza Immunization Coalition Encourages Vaccination Throughout the Influenza Season

... must be dispelled," said Coalition Moderator, Carol J. Baker, M.D., FAAP, FIDSA, President of NFID and Professor of Pediatrics, Molecular virology and Microbiology, Baylor College of Medicine. "Because influenza can continue to circulate as late as May, we need to continue providing influenza ...

Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles

... About Epiphany Biosciences Epiphany Biosciences is focused on advancing new therapies for viral disease. Epiphany has formed a world-class virology team that includes two Lasker Award winners. Epiphany is located in San Francisco, CA. Additional information on Epiphany Biosciences may be obtained ...

Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions

... people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous ....

Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week

... people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps

... people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche

... people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006, sales by the ...

NanoViricides Drugs Found To Be Highly Effective Against Most Recent Strain of the H5N1 Avian Flu Virus

... of the Pan American Society for Clinical virology in Tampa, FL, on Wednesday, May 2. (Pan American Society for Clinical virology (PASCV): Clinical virology Symposium) The BSL3 studies against Clade 2 ...

Global Rabies Treatment May be Possible with NanoViricides Drugs

... in Tampa, FL, on Wednesday, May 2. (Pan American Society for Clinical virology (PASCV): Clinical virology Symposium) The animal studies against rabies were conducted in ...

Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University

... of Vaxiion Therapeutics Inc. who received both M.S. and MBA degrees at SDSU; and Maria Salvato and Juan C. Zapata with the Institute of Human virology at the University of Maryland Biotechnology Institute. Vaxiion Therapeutics Inc. is dedicated to the intelligent design of effective vaccines and ...

New Data from the US and Japan Support: No Established Causal Link Between Neuropsychiatric Symptoms and Treatment with Tamiflu US Databases Indicate Psychiatric Symptoms Lower in Influenza Patients Taking Tamiflu Versus Those Not Taking Tamiflu

... improving people's health and quality of life. Roche is the world leader in diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine

... Corp. (AMEX:INO), which is focused on the development of DNA vaccines and a novel solid tumor ablation therapy, announced today that the Journal of virology has published a scientific paper prepared by Inovio's development partner, Wyeth, regarding results from a non-human primate study of an ...

Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV Activity

... The company has initiated one of the industry's broadest efforts in working on the development of numerous ligase targets in oncology, inflammation, virology and metabolism. Rigel was one of the first companies to discover potent and highly selective small molecule inhibitors of ubiquitin ligases. Rigel ...

Achillion Presents Positive Data on Novel Mechanism for Treating HCV at EASL Annual Meeting

... "In Vitro Evaluation of Combination Treatment of ACH-806 with Interferon, VX-950 and NM 107," was led by Mingjun Huang, Ph.D., Senior Director of virology at Achillion, who discussed in vitro evaluations of ACH-806 in combination with interferon, a protease inhibitor, and a polymerase inhibitor. The ...

New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People

... improving people's health and quality of life. Roche is the world leader in diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen

... people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma

... people_s health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone

... health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin

... health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...

New Data Confirms Significant Improvement of Disease Signs and Symptoms in Patients with Rheumatoid Arthritis

... health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006 sales by the ...
Other Contentsalbuminalbuminalbuminalbuminalbuminalbuminalbuminalbuminalbuminfrequencyfrequencyfrequencyfrequencyfrequencyfrequencyfrequencyfrequencyfrequencyallelealleleallelealleleallelealphaalphaalphaalphaalphaalphaalphaalphaalternativealternativealternativealternativealternativealternativealternativealternativealternativeamineamineamineaminoaminoaminoaminoaminoaminoaminoaminoamino
(Date:12/16/2009)... European Union (EU) member states are spending ... increasingly subjected to unauthorised immigration and illegal ... security and IT-based systems will boost the ... ) ,, New analysis from Frost & ... Market Assessment - European Union , finds ...
(Date:12/15/2009)... As soon as babies are born, they are ... e-coli. For up to a month, their immune systems ... are often minor, they can lead to serious problems ... University of Missouri researchers have pinpointed a group of ... immune-strengthening vaccine. , "We,re trying to improve the immune ...
(Date:12/15/2009)... has just signed an agreement with the British Society ... affiliation with the journal Biogerontology for an ... appoint one member of the Biogerontology editorial ... annually. Springer will sponsor the society and provide ... on www.springerlink.com . , Biogerontology ...
Breaking Biology News(10 mins):Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3Researchers work on vaccine to improve immune system in newborns 2St Davids South Austin Hospital Leading the Central Texas Region in Laser Assisted Lead Extraction Procedures 5886 1St Davids South Austin Hospital Leading the Central Texas Region in Laser Assisted Lead Extraction Procedures 5886 2St Davids South Austin Hospital Leading the Central Texas Region in Laser Assisted Lead Extraction Procedures 5886 3Leave It To Beaver Star Visits Kannapolis to Promote Prescription Assistance 5882 1Leave It To Beaver Star Visits Kannapolis to Promote Prescription Assistance 5882 2MedImmune to present 4 abstracts on RSV and influenza at 47TH Annual IDSA Meeting 60410 1MedImmune to present 4 abstracts on RSV and influenza at 47TH Annual IDSA Meeting 60410 2MedImmune to present 4 abstracts on RSV and influenza at 47TH Annual IDSA Meeting 60410 3
(Date:12/16/2009)... OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced Alison Davies as ... Ms. Davies has spent the last fourteen ... industry, most recently for nine years as a ... of Invisalign . ,, (Logo: ...
(Date:12/16/2009)... -- MassMutual,s Retirement Services Division has announced plans ... in Q2 2010. The new platform will include ... change materials in a variety of themes. Plan ... a menu of creative options to support the ... The new RetireSmart participant engagement platform will be ...
(Date:12/16/2009)... diagnostic procedures in cardiology. The idea of publishing an ... of European cardiovascular imagers, is therefore long awaited. The ... with a patient rather than technology-based approach, helping clinicians ... aid of imaging. , The book is divided ... practice of cardiac imaging and its clinical use in ...
(Date:12/16/2009)... of Fortune 1000 employers strongly indicates that wellness programs have ... , ... Minneapolis, MN (PRWEB) December ... reveals that 78 percent of employers have improved employee participation ... In the survey, conducted by Hallmark Insights, a ...
(Date:12/16/2009)... Tyco International Ltd. (NYSE: TYC ) ... for election to the Tyco Board of Directors ... 10, 2010. ,, Daniels, 55, is Senior ... of International Business Machines Corporation. In this role, ... business operations consisting of outsourcing services, integrated technology ...
Breaking Medicine News(10 mins):Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2
Other TagsReciprocatingPlateletPlateletAUTIONEstriolUnconjugatedSerologicalSoftGripReservoirOther Tagsdesign 2design 3design 4design 5design 6design 7design 8design 9design 10polyphenols 2retinal 2retinal 3retinal 4ignorant 2orange 2acidity 2general 2general 3general 4general 5general 6general 7general 8general 9general 10